Literature DB >> 19829739

In favour of bladder preservation using combined modality treatment.

Himu Lukka1.   

Abstract

Year:  2009        PMID： 19829739      PMCID： PMC2758518          DOI： 10.5489/cuaj.1157

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  22 in total

Review 1.  Invasive bladder cancer: organ preservation by radiochemotherapy.

Authors:  C Rödel; G G Grabenbauer; R Kühn; J Dunst; T Papadopoulos; K M Schrott; R Sauer
Journal:  Front Radiat Ther Oncol       Date:  2002

2.  Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2.

Authors:  Amir Sherif; Erkki Rintala; Oddvar Mestad; Jonas Nilsson; Lars Holmberg; Sten Nilsson; Per-Uno Malmström
Journal:  Scand J Urol Nephrol       Date:  2002

Review 3.  Surgery and adjunctive chemotherapy for invasive bladder cancer.

Authors:  Derek Raghavan; David Quinn; Donald G Skinner; John P Stein
Journal:  Surg Oncol       Date:  2002-06       Impact factor: 3.279

4.  Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire.

Authors:  O Caffo; G Fellin; U Graffer; L Luciani
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

5.  Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

Authors:  C M Coppin; M K Gospodarowicz; K James; I F Tannock; B Zee; J Carson; J Pater; L D Sullivan
Journal:  J Clin Oncol       Date:  1996-11       Impact factor: 44.544

6.  Alternating chemo-radiotherapy in bladder cancer: a conservative approach.

Authors:  M Orsatti; A Curotto; L Canobbio; D Guarneri; D Scarpati; M Venturini; P Franzone; S Giudici; G Martorana; F Boccardo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

7.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

Authors:  W U Shipley; D S Kaufman; E Zehr; N M Heney; S C Lane; H K Thakral; A F Althausen; A L Zietman
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

8.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

9.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

10.  Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.

Authors:  P U Malmström; E Rintala; R Wahlqvist; P Hellström; S Hellsten; E Hannisdal
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.